SRSF1 mediates cytokine-induced impaired imatinib sensitivity in chronic myeloid leukemia
Sign Up to like & getrecommendations! Published in 2020 at "Leukemia"
DOI: 10.1038/s41375-020-0732-1
Abstract: Patients with chronic myeloid leukemia (CML) who are treated with tyrosine kinase inhibitors (TKIs) experience significant heterogeneity regarding depth and speed of responses. Factors intrinsic and extrinsic to CML cells contribute to response heterogeneity and… read more here.
Keywords: cml; imatinib sensitivity; impaired imatinib; srsf1 ... See more keywords